Market Overview

Charles River Labs Closes Purchase of Majority Ownership of Vital River

Related CRL
Positives In Charles River Labs 'Largely Reflected In Industry-High Valuation'
Mid-Morning Market Update: Markets Open Higher; Time Warner Posts Mixed Q4 Results
Charles River Labs buys CRO specializing in biologics and biosimilars (Seeking Alpha)

Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it has completed its acquisition of a 75% ownership of Vital River, the premier commercial provider of research models and related services in China, and a licensee of Charles River for the last ten years.

Posted-In: News M&A


Related Articles (CRL)

View Comments and Join the Discussion!